Oncology Journal Citation Rate 2026
0030-2414
eISSN 1423-0232
Karger Publishers
CH
Q3 Quartile
About Oncology
Oncology (O) is a peer-reviewed academic journal, published by Karger Publishers in CH, catalogued under ISSN 0030-2414 (e-ISSN 1423-0232). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.38 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Oncology Citation Rate 2026 — In Context
Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 1.38, placing it in the Q3 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Oncology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Oncology against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 0030-2414 |
|---|---|
| ISSN (Online) | 1423-0232 |
| Publisher | Karger Publishers |
| Country | Switzerland |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Oncology is published by Karger Publishers and based in Switzerland.
Oncology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.379.
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Oncology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.379 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
CD2 costimulation breaks the CD28 vs. 4-1BB tradeoff in CAR T cells
Avery D. Posey • 2026
-
Platelet-to-high-density lipoprotein ratio predicts postoperative overall survival in hepatocellular carcinoma: a retrospective cohort study
Xiong Tang, Lu-Yun Zhang, Jia-Peng Liao • 2026
-
Symptom networks in breast cancer patients during chemotherapy and their impact on daily living status
Yuxuan Zhang, Huoling Pan, Jinyu Zhang • 2026
-
Machine learning models based on tumoral, 4 mm-peritumoral, and combined radiomic features for evaluating the invasiveness of lung adenocarcinoma manifesting as ground-glass nodules
Hui Xue, Xin Pang, Jing Liu • 2026
-
Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance
Haoxiang Zhang, Chuanbing Zhao, Jiaoshun Chen • 2026
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S198727964
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.